Resistance to Immunotoxins in Cancer Therapy / Resistance to Targeted Anti-Cancer Therapeutics Bd.6 (PDF)

Name: Resistance to Immunotoxins in Cancer Therapy / Resistance to Targeted Anti-Cancer Therapeutics Bd.6
Brand: Springer-Verlag GmbH
SKU: 69846087
Price: 98.99 EUR
Availability: OnlineOnly

(Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Resistance to Immunotoxins in Cancer Therapy / Resistance to Targeted Anti-Cancer Therapeutics Bd.6".

Merken

Mehr zum Inhalt Autorenporträt Video

eBook (pdf) 98.99 €

Buch (Gebunden) 109.99 €

sofort als Download lieferbar

Bestellnummer: 69846087

Printausgabe 109.99 €

eBook (pdf) -10% 98.99 €

Download bestellen

Verschenken

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Resistance to Immunotoxins in Cancer Therapy / Resistance to Targeted Anti-Cancer Therapeutics Bd.6 (PDF)“

This volume is a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. It contains a detailed review of the history and development of targeted therapy. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance. Each chapter discusses different aspects of resistance and covers all the factors that may contribute to resistance in cancer cells. Finally, this volume highlights the recent findings and advances associated with tackling cancer resistance.

Autoren-Porträt

Rama Shanker Verma, Ph.D., is Professor, Department of Biotechnology, the Indian Institute of Technology. Professor Verma specializes in the development of novel immunotoxins for cancer therapies. He has published 76 scientific articles, five book chapters, and several conference abstracts. He is an Elected Fellow, the Association of Microbiologists of India an Elected Fellow, the Society for Applied Biotechnology. He received the award for Excellence in Medical Biotechnology from the Society for Applied Biotechnology.